David Feder

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

The use of vancomycin with its therapeutic and adverse effects: a review.

Felipe Ribeiro Bruniera, Felipe Ferreira, L R M Saviolli et al. · PubMed · 2015 · 277 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy

Nathalie Goemans, Eugenio Mercuri, Hirofumi Komaki et al. · Neuromuscular Disorders · 2017 · 128 citations · Full text

Medicine, Molecular Medicine, Neuromuscular Disorders +7

Improved Biochemical Outcomes With Statin Use in Patients With High-Risk Localized Prostate Cancer Treated With Radiotherapy

Marisa Kollmeier, Matthew S. Katz, Kimberley S. Mak et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 90 citations

Medicine, Oncology, Pharmacotherapy +13

IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients

Marcelo Rodrigues Bacci, Rodrigo Cuiabano Paes Leme, Natalia Pin Chuen Zing et al. · Brazilian Journal of Medical and Biological Research · 2015 · 90 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14